Clinical Trial Update: To Evaluate the Efficacy, Safety, and Immunogenicity of Subcutaneous Eporon Versus Epoetin Alfa (Eprex) [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating subcutaneous Eporon versus epoetin alfa for anemia of chronic kidney disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia of Chronic Kidney Disease

Drugs mentioned

• EPOETIN ALFA (EPOETIN ALFA)
• EPORON

Snippet

Sponsor: Dong-A ST Co., Ltd. | Conditions: Anemia of Chronic Kidney Disease | Phase 3 | Status: UNKNOWN